Sunho Biologics Inc banner

Sunho Biologics Inc
HKEX:2898

Watchlist Manager
Sunho Biologics Inc Logo
Sunho Biologics Inc
HKEX:2898
Watchlist
Price: 6.4 HKD
Market Cap: HK$1B

Sunho Biologics Inc
Investor Relations

Sunho Biologics, Inc. operates as a biopharmaceutical company. The company is headquartered in Huzhou, Zhejiang and currently employs 128 full-time employees. The company went IPO on 2024-05-24. The firm is primarily engaged in the discovery, development and commercialization of biologics that modulate the immune microenvironment by directly modulating the innate and adaptive immune systems. The firm has three core products, namely IAH0968, IAP0971 and IAE0972. IAH0968 is an antibody-dependent cell-mediated cytotoxicity-enhancing monoclonal antibody. IAP0971 and IAE0972 are both antibody cytokines.

Show more
Loading
2898
Hang Seng (Hong Kong)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Contacts

Address
ZHEJIANG
Huzhou
Room 302, Building 3, No. 198 Peninsula Middle Road, Dipu Street, Anji County
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett